Innere Medizin (Heidelberg, Germany)最新文献

筛选
英文 中文
[Transition in patients with cystic fibrosis and asthma]. [囊性纤维化和哮喘患者的转变]。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 Epub Date: 2025-05-14 DOI: 10.1007/s00108-025-01912-6
Margarete Olivier, Florian Stehling, Christian Taube, Matthias Welsner
{"title":"[Transition in patients with cystic fibrosis and asthma].","authors":"Margarete Olivier, Florian Stehling, Christian Taube, Matthias Welsner","doi":"10.1007/s00108-025-01912-6","DOIUrl":"10.1007/s00108-025-01912-6","url":null,"abstract":"<p><p>Adolescence represents a period of significant transformation for individuals with chronic conditions such as cystic fibrosis (CF) and asthma. Due to substantial progress in highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy, nearly everyone with CF now reaches adulthood, necessitating ongoing interdisciplinary medical care. Conversely, approximately 70% of children with asthma experience a resolution of symptoms as they reach adulthood. Factors contributing to the persistence of asthma into adulthood include the presence of severe asthma, diminished lung function in childhood and allergic comorbidities. Especially for young adults with severe asthma, continuous pneumological care including uninterrupted access to biologics, must be provided. During the transition process, considerations regarding career choices are pertinent for both patient groups. Additionally, issues related to family planning and prenatal diagnostics become particularly relevant for young adults with CF and should be addressed during the transition process. In both patient groups, an early and structured initiation of the transition process is essential. The use of checklists and transition plans can facilitate the transfer of critical information and ensure a seamless transition. Joint pediatric and internal medicine consultations foster trust and ensure medical quality. Ultimately, a successful transition should enable individuals with CF as well as those with asthma to assume responsibility for their condition and treatment, recognize clinical deterioration, and seek timely assistance.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":" ","pages":"586-592"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diagnostics and treatment of osteoporosis in 2025 : An update on current guidelines]. [2025年骨质疏松症的诊断和治疗:当前指南的更新]。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 Epub Date: 2025-05-16 DOI: 10.1007/s00108-025-01884-7
Philipp Klemm, Nils Schulz, Uwe Lange, Björn Bühring
{"title":"[Diagnostics and treatment of osteoporosis in 2025 : An update on current guidelines].","authors":"Philipp Klemm, Nils Schulz, Uwe Lange, Björn Bühring","doi":"10.1007/s00108-025-01884-7","DOIUrl":"10.1007/s00108-025-01884-7","url":null,"abstract":"<p><p>Osteoporosis is a relevant public health issue characterized by reduced bone mass and impaired bone microarchitecture, leading to an increased fracture risk. Osteoporosis is diagnosed based on low bone mineral density (BMD), specific fragility fractures and/or an elevated fracture risk. The BMD is one of the most important risk factors for the increased fracture risk that defines osteoporosis, alongside age and sex. Accordingly, treatment strategies focus on reducing the fracture risk. Risk gradients and an algorithm for fracture risk assessment guide treatment decisions. A primary osteoanabolic treatment is recommended for individuals with a 3-year fracture risk of 10% or higher and antiresorptive treatment where the risk exceeds 3%. The high disease burden and gaps in care highlight the need for targeted interventions. The introduction of new guidelines in Germany and Austria provides clear and individualized recommendations for action for the diagnosis and treatment of osteoporosis.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":" ","pages":"603-614"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fortbildungen des BDI. BDI培训。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 DOI: 10.1007/s00108-025-01914-4
{"title":"Fortbildungen des BDI.","authors":"","doi":"10.1007/s00108-025-01914-4","DOIUrl":"https://doi.org/10.1007/s00108-025-01914-4","url":null,"abstract":"","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 6","pages":"624-627"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A rare differential diagnosis of fever of unknown origin]. 【不明原因发热的罕见鉴别诊断】。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 Epub Date: 2025-03-10 DOI: 10.1007/s00108-025-01864-x
Sabrina Welland, Linus Risser, René Abu Isneineh
{"title":"[A rare differential diagnosis of fever of unknown origin].","authors":"Sabrina Welland, Linus Risser, René Abu Isneineh","doi":"10.1007/s00108-025-01864-x","DOIUrl":"10.1007/s00108-025-01864-x","url":null,"abstract":"<p><p>A 22-year-old male patient with a clinical picture similar to that of sepsis was diagnosed with macrophage activation syndrome in adult Still's disease on the basis of clinical and laboratory criteria. The diagnostic work-up included the differentiated clarification of a persistent fever syndrome and the differential diagnosis of hemophagocytic lymphohistiocytosis. Immunosuppressive therapy with dexamethasone, immunoglobulins and anakinra was initiated and a sustained clinical remission was achieved.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":" ","pages":"646-650"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transition]. (过渡)。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 DOI: 10.1007/s00108-025-01929-x
Dagmar Führer-Sakel, Ursula Felderhoff-Müser, Britta Siegmund, Lars Pape
{"title":"[Transition].","authors":"Dagmar Führer-Sakel, Ursula Felderhoff-Müser, Britta Siegmund, Lars Pape","doi":"10.1007/s00108-025-01929-x","DOIUrl":"https://doi.org/10.1007/s00108-025-01929-x","url":null,"abstract":"","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 6","pages":"561-562"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Koalitionsvertrag. 执政联盟协议.
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 DOI: 10.1007/s00108-025-01915-3
{"title":"Koalitionsvertrag.","authors":"","doi":"10.1007/s00108-025-01915-3","DOIUrl":"https://doi.org/10.1007/s00108-025-01915-3","url":null,"abstract":"","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 6","pages":"615-623"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen der DGIM. DGIM通讯。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-06-01 DOI: 10.1007/s00108-025-01909-1
{"title":"Mitteilungen der DGIM.","authors":"","doi":"10.1007/s00108-025-01909-1","DOIUrl":"https://doi.org/10.1007/s00108-025-01909-1","url":null,"abstract":"","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 6","pages":"628-638"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Obesity as a chronic disease]. [肥胖是一种慢性疾病]。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-05-01 Epub Date: 2025-03-26 DOI: 10.1007/s00108-025-01883-8
Pia Roser, Jens Aberle
{"title":"[Obesity as a chronic disease].","authors":"Pia Roser, Jens Aberle","doi":"10.1007/s00108-025-01883-8","DOIUrl":"10.1007/s00108-025-01883-8","url":null,"abstract":"<p><p>The global prevalence of obesity has more than tripled since 1975 and represents a substantial public health challenge. Obesity is a chronic disease with a high tendency to recurrence and is associated with numerous comorbidities, such as diabetes mellitus, high blood pressure and cardiovascular diseases. Every year around 2.8 million people die from the sequelae. Obesity is defined as the excessive accumulation of fatty tissue. In routine clinical practice obesity is diagnosed by measuring the body mass index (BMI); however, there are numerous professional associations that recommend the additional determination of another biometric parameter (waist to height ratio or waist circumference). This not only reduces inaccuracies in the BMI but also makes it easier to identify patients with a particularly high risk of cardiovascular and metabolic diseases. Regardless of the definitions and diagnostics of obesity, the aim of treatment for those affected is not just to reduce weight but more to improve the quality of life, overall survival and the improvement or prevention of obesity-related diseases.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":" ","pages":"447-452"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pancreatitis from drugs-Drugs for treatment of pancreatitis]. [药物引起的胰腺炎-治疗胰腺炎的药物]。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-05-01 Epub Date: 2025-04-29 DOI: 10.1007/s00108-025-01888-3
Max Ole Hubert, Julia Mayerle, Simon Sirtl
{"title":"[Pancreatitis from drugs-Drugs for treatment of pancreatitis].","authors":"Max Ole Hubert, Julia Mayerle, Simon Sirtl","doi":"10.1007/s00108-025-01888-3","DOIUrl":"10.1007/s00108-025-01888-3","url":null,"abstract":"<p><strong>Background: </strong>Drugs are a rare but important cause of acute pancreatitis (AP) due to potential therapeutic consequences, accounting for up to 5% of all cases of AP. The diagnosis of drug-induced AP is challenging due to mostly weak evidence and complex diagnostic criteria.</p><p><strong>Objective: </strong>This review article defines drug-induced AP, summarizes the evidence for drugs associated with AP and highlights the challenges in the diagnosis of this condition. The second part of the article focuses on the main pillars of AP treatment.</p><p><strong>Current data: </strong>The association of most drugs associated with AP is based on case reports and case series but there are no high-quality studies. There is sufficient evidence of a causal relationship for only 40 of more than 500 drugs associated with AP and for almost none of the drugs the causal mechanism has been definitively clarified. Several classification systems and criteria have been proposed to assess whether a drug causally triggers AP, with criteria including the temporal association, the exclusion of other causes and recurrence of AP after re-exposure.</p><p><strong>Conclusion: </strong>The diagnosis of drug-induced AP remains a challenge, with many common drugs being incorrectly associated with AP. There is an urgent need for the development of biomarkers to facilitate the diagnosis of drug-induced AP. Drug treatment for AP is still primarily a needs-based fluid management and efficient analgesia. New and causal therapeutic approaches need clinical validation.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 5","pages":"524-532"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144030196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rare diseases: the role of internal medicine]. 【罕见病:内科的作用】。
Innere Medizin (Heidelberg, Germany) Pub Date : 2025-05-01 Epub Date: 2025-04-24 DOI: 10.1007/s00108-025-01892-7
Tilman Sauerbruch, Stefan Aretz, Helge Hebestreit, Harald Kaemmerer, Lutz Nährlich, Britta Siegmund, Georg Ertl
{"title":"[Rare diseases: the role of internal medicine].","authors":"Tilman Sauerbruch, Stefan Aretz, Helge Hebestreit, Harald Kaemmerer, Lutz Nährlich, Britta Siegmund, Georg Ertl","doi":"10.1007/s00108-025-01892-7","DOIUrl":"10.1007/s00108-025-01892-7","url":null,"abstract":"<p><p>Rare diseases, defined in the European Union as conditions affecting fewer than five per 10,000 inhabitants, often manifest themselves in childhood, but are playing an increasingly important role in internal medicine due to the significantly improved long-term prognosis and a number of diseases that primarily occur in adulthood. Although noteworthy structures already exist nationally and internationally (networks, registers, databases, self-help groups), awareness of these diseases in daily routine and knowledge of the partly divergent care structures must be improved. There are no specific treatments for many of these diseases, but drugs are increasingly being developed-particularly in oncology-that are subject to special orphan drug status.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":"66 5","pages":"533-539"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12053190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信